Lundberg, Per Johan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lundberg, Per Johan.The latest application filed is for "non-donating nsaids adsorbed into carrier particles".
- Lundberg, Per Johan - Molndal SE
| Patent | Date |
|---|---|
| Non-donating nsaids adsorbed into carrier particles App 20050129774 - Morein, Sven ; et al. | 2005-06-16 |
| Pharmaceutical formulation and process App 20040234594 - Lundberg, Per Johan ; et al. | 2004-11-25 |
| Matrix pellets for greasy, oily or sticky drug substances App 20030175352 - Karlsson, Christer ; et al. | 2003-09-18 |
| Oral pharmaceutical pulsed release dosage form Grant 6,610,323 - Lundberg , et al. August 26, 2 | 2003-08-26 |
| Oral pharmaceutical extended release dosage form Grant 6,605,303 - Karehill , et al. August 12, 2 | 2003-08-12 |
| Pharmaceutical formulation and process App 20030113375 - Lundberg, Per Johan ; et al. | 2003-06-19 |
| Porous hydroxyapatite particles as carriers for drug substances Grant 6,558,703 - Karlsson , et al. May 6, 2 | 2003-05-06 |
| Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances Grant 6,555,138 - Karlsson , et al. April 29, 2 | 2003-04-29 |
| Pharmaceutical formulation and process App 20020086029 - Lundberg, Per Johan ; et al. | 2002-07-04 |
| New Pharmaceutical Formulation And Process App 20020012676 - LUNDBERG, PER JOHAN ; et al. | 2002-01-31 |
| Multiple unit effervescent dosage form Grant 6,284,271 - Lundberg , et al. September 4, 2 | 2001-09-04 |
| Multiple unit effervescent dosage forms comprising proton pump inhibitor Grant 6,132,770 - Lundberg October 17, 2 | 2000-10-17 |
| Pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound Grant 6,086,919 - Bauer , et al. July 11, 2 | 2000-07-11 |
| Method of making a pharmaceutical dosage form comprising a proton pump inhibitor Grant 6,013,281 - Lundberg , et al. January 11, 2 | 2000-01-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 